Strategia Therapeutics Inc Headquarters
The links below provide all the necessary information about Strategia Therapeutics Inc Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
Home - Strategia
- https://strategiatx.com/
- A New Vision. A Better Future for Patients. Strategia Pharmaceuticals offers a new model for effective drug research and development for patients. Together, we have re-designed the process by which therapeutics are developed, with the goal of providing new therapies to patients faster, more efficiently, and at a lower overall cost.
Strategia Therapeutics - Overview, News & Competitors
- https://www.zoominfo.com/c/strategia-therapeutics-inc/369407925
- Strategia Therapeutics’s headquarters are in 27 Strathmore Rd, Natick, Massachusetts, 01760, United States What is Strategia Therapeutics’s phone number? Strategia Therapeutics’s phone number is (781) 761-0123
Strategia Therapeutics, Inc. Information | Strategia …
- https://rocketreach.co/strategia-therapeutics-inc-profile_b5497a60f6774395
- Strategia Therapeutics offers a fresh approach to drug research and development. We deliver therapeutics faster, more efficiently, and at lower cost to patients than existing R&D models. The problem: inefficiency drives cost The pharmaceutical industry is facing a productivity crisis.
Overview - Strategia
- https://strategiatx.com/about-us/overview/
- A new vision. A better future for patients. Strategia Pharmaceuticals offers a fresh approach to drug research and development. We deliver therapeutics faster, more efficiently, and at lower cost to patients than existing R&D models. The problem: inefficiency drives cost The pharmaceutical industry is facing a productivity crisis. In recent years, the costs of drug […]
Strategia Therapeutics, Inc. in Boston, MA | Company Info & Reviews
- https://www.bizapedia.com/ma/strategia-therapeutics-inc.html
- Strategia Therapeutics, Inc. is a Massachusetts Foreign Corporation filed On April 10, 2015. The company's File Number is listed as 001168750 . The Registered Agent on file for this company is Keizo Koya and is located at 214 Union Wharf, Boston, MA 02109.
Strategia Team - Strategia
- https://strategiatx.com/about-us/strategy-experts/
- Keizo Koya, PhD, Founder, President and CEO. Dr. Keizo Koya is a dynamic leader, senior executive, and entrepreneur with three decades of experience in global pharmaceutical R&D and business strategy. In 2012, he formed Strategia Therapeutics, Inc. to implement his visionary new model for collaborative drug development, and established global ...
Boston Strategic Corporation Announces Name To …
- https://www.businesswire.com/news/home/20150408005176/en/Boston-Strategic-Corporation-Announces-Strategia-Therapeutics
- Company Name: Strategia Therapeutics, Inc. President and CEO: Keizo Koya, Ph.D. Headquarter Address: 214 Union Wharf, Boston, MA 02109-1204, USA About Strategia Therapeutics, Inc. ( Strategia )
Strategia Holdings LLC | LinkedIn
- https://www.linkedin.com/company/strategiaholdings
- Strategia Holdings LLC | 337 followers on LinkedIn. Strategia is an innovative pharmaceutical R&D company with experience in developing, managing …
Strategia Therapeutics Announces New Website Launch
- http://strategiatx.com/wp-content/uploads/2015/08/Strategia_PR_8-10_2015_Eng.pdf
- expertise specific to a single drug. By focusing its efforts in this way, Strategia rapidly and successfully moves each project forward to completion while keeping internal infrastructure small and streamlined. Contact: Strategia Therapeutics, Inc. +1-781-761-0123 (office) [email protected] (email) http://www.StrategiaTx.com (website)
Strategia Therapeutics, Inc. BSC-101-01
- https://clinicaltrials.gov/ProvidedDocs/00/NCT02418000/SAP_000.pdf
- Strategia Therapeutics, Inc. BSC-101-01 A Phase 1/2a study of E6201 for the treatment of advanced hematologic malignancies with FLT3 and/or Ras mutations, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) Statistical Analysis Plan October 19, 2017 Version 1.0 Westat
Sarepta Therapeutics | Biopharmaceutical Company for Rare …
- https://www.sarepta.com/
- We see a revolution. Sarepta is a global biotechnology company on an urgent mission: engineer precision genetic medicine to reclaim futures otherwise impacted or cut short by rare diseases. We’re ushering in a new era of drug development, with the goal of shortening the time from lab to patient, building the world’s largest gene therapy ...
Onkaido Therapeutics - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/onkaido-therapeutics
- Headquarters Regions Greater Boston Area, East Coast, New England; Founded Date 2013; Founders Stephen Hoge; Operating Status Closed; Last Funding Type Venture - Series Unknown; Company Type For Profit; Contact Email [email protected]; Phone Number 617-583-1998
Home | Sigilon
- https://sigilon.com/
- We developed our Shielded Living Therapeutics™ platform to address these treatment challenges. Leveraging advances in cell engineering and our proprietary biocompatible materials, we created a pipeline of potential therapies capable of producing proteins, enzymes and other therapeutic molecules that may be missing or deficient in the body ...
Establishing a Better Microbiome for Better Health - Seres …
- https://www.serestherapeutics.com/
- Realizing the possibilities within. Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. About Us. Our Platform. Our Programs. Patients and Physicians. Open Positions. Investors and News. Inside Seres.
Did you find out everything you wanted about Strategia Therapeutics Inc Headquarters?
We are sure that the information collected for you about Strategia Therapeutics Inc Headquarters turned out to be more than enough.
